Integral Diagnostics Limited (IDX.AX) Stock Analysis & Winston Score
Integral Diagnostics is an Australian medical imaging company. It operates a network of radiology clinics where patients go to get scans like X-rays, MRIs, CT scans, and ultrasounds. Doctors refer patients to these clinics to help diagnose injuries, diseases, and other health conditions across Australia and New Zealand. The company earns revenue each time a patient receives an imaging scan, with fees largely funded through Australia's Medicare public health system and private health insurers. Integral Diagnostics operates dozens of clinics primarily in regional and suburban markets across Australia and New Zealand, giving it a geographic footprint that is harder for new competitors to replicate quickly. The business faces ongoing pressure from radiologist shortages and rising labor costs, which weigh on margins, and its ability to grow depends on expanding its clinic network through acquisitions and improving the efficiency of its existing locations.
Winston Score: 43/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (8/30)
- Growth: Good (13/20)
- Cash Flow: Strong (7/10)
- Stability: Good (5/10)
- Valuation: Weak (1/10)
- Ownership: Ownership data not available (not counted) (0/15)


